Cargando…

Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective

SIMPLE SUMMARY: Anticancer nucleoside analogs are promising treatments that often result in damaging toxicities and therefore ineffective treatment. Mechanisms of this are not well-researched, but cellular nucleoside transport research in mice might provide additional insight given transport’s role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Syed Saqib, Raj, Ruchika, Kaur, Tejinder, Weadick, Brenna, Nayak, Debasis, No, Minnsung, Protos, Jane, Odom, Hannah, Desai, Kajal, Persaud, Avinash K., Wang, Joanne, Govindarajan, Rajgopal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264962/ https://www.ncbi.nlm.nih.gov/pubmed/35804885 http://dx.doi.org/10.3390/cancers14133113

Ejemplares similares

EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer
por: Nayak, Debasis, et al.
Publicado: (2022)

Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
por: Persaud, Avinash K., et al.
Publicado: (2023)

Author Correction: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice
por: Persaud, Avinash K., et al.
Publicado: (2023)

Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors
por: Persaud, Avinash K., et al.
Publicado: (2021)

Identification of Structural and Molecular Features Involved in the Transport of 3′-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
por: Rahman, MD Fazlur, et al.
Publicado: (2018)

Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016)

Hematopoiesis and microenvironment in hematological malignancies
por: Cheng, Hui, et al.
Publicado: (2018)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

CircRNAs in hematopoiesis and hematological malignancies
por: Bonizzato, A, et al.
Publicado: (2016)

The hedgehog pathway in hematopoiesis and hematological malignancy
por: Lemos, Tucker, et al.
Publicado: (2022)

EZH2 in normal hematopoiesis and hematological malignancies
por: Herviou, Laurie, et al.
Publicado: (2015)

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
por: Sarodaya, Neha, et al.
Publicado: (2020)

Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies
por: Zuo, Fengli, et al.
Publicado: (2022)

In Vivo Chemical Screening for Modulators of Hematopoiesis and Hematological Diseases
por: Zhang, Yiyun, et al.
Publicado: (2012)

Contribution of extracellular vesicles in normal hematopoiesis and hematological malignancies
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress
por: Austin, Wayne R., et al.
Publicado: (2012)

Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies
por: Wang, Zi, et al.
Publicado: (2021)

The Beginning of the Road for Non-Coding RNAs in Normal Hematopoiesis and Hematologic Malignancies
por: Heuston, Elisabeth F., et al.
Publicado: (2011)

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology
por: Hoermann, Gregor, et al.
Publicado: (2020)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
por: Hoermann, Gregor
Publicado: (2022)

The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies
por: Zhang, Hengwei, et al.
Publicado: (2023)

Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
por: Zhao, Ailin, et al.
Publicado: (2023)

Pharmacological Reversal of Histone Methylation Presensitizes Pancreatic Cancer Cells to Nucleoside Drugs: In Vitro Optimization and Novel Nanoparticle Delivery Studies
por: Hung, Sau Wai, et al.
Publicado: (2013)

Adult stem cell deficits drive Slc29a3 disorders in mice
por: Nair, Sreenath, et al.
Publicado: (2019)

Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
por: Zhao, Huijuan, et al.
Publicado: (2022)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Hematologic Features of Alpha Thalassemia Carriers
por: Akhavan-Niaki, Haleh, et al.
Publicado: (2012)

Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?
por: Cumbo, Cosimo, et al.
Publicado: (2022)

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
por: Gondek, Lukasz P., et al.
Publicado: (2022)

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
por: Gaulin, Charles, et al.
Publicado: (2022)

Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
por: Zhao, Huijuan, et al.
Publicado: (2023)

ENT3 utilizes a pH Sensing Mechanism for Transport
por: Singh, Anusha, et al.
Publicado: (2017)

Mitochondrial toxicities of nucleoside analogue reverse transcriptase inhibitors in AIDS cases
por: Marfatia, Yogesh S., et al.
Publicado: (2014)

Anion exchange resins in phosphate form as versatile carriers for the reactions catalyzed by nucleoside phosphorylases
por: Artsemyeva, Julia N, et al.
Publicado: (2020)

Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders
por: Midic, Danica, et al.
Publicado: (2020)

Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers
por: Massaro, Fulvio, et al.
Publicado: (2020)

PB2200: CLONAL HEMATOPOIESIS AT THE CROSSROADS OF INFLAMMATORY BOWEL DISEASES AND HEMATOLOGICAL MALIGNANCIES: A BIOLOGICAL LINK?
por: Cumbo, C., et al.
Publicado: (2022)

Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
por: Johnson, Zachary Lee, et al.
Publicado: (2014)

Sex Differences in the Spectrum of Clonal Hematopoiesis
por: Kamphuis, Priscilla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_opnf3cfumqj0gqnf1l6br30gfg